Showing results (2071-2080 of 2,144) with videos related to

Sort By:
Pageof 215
Vaccine|March 2, 2010
In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7 x 10(10) colony-forming unitsC E Lyon, K S Sadigh, M P Carmolli, et al.
JHEP Reports : Innovation in Hepatology|April 8, 2026
Radiation-induced lymphopenia is associated with survival in patients with hepatocellular carcinoma treated with stereotactic body radiotherapyLandon L Chan, Vanessa T Y Yeung, Winnie M T Soo, et al.
Cancer Chemotherapy and Pharmacology|August 4, 2009
SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivoJennifer P Arbitrario, Brian J Belmont, Marc J Evanchik, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 30, 2020
Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) ReportKatharine Dunlop, Sakina J Rizvi, Sidney H Kennedy, et al.
Plos One|July 26, 2016
Relations between Recent Past Leisure Activities with Risks of Dementia and Cognitive Functions after StrokeAdrian Wong, Alexander Y L Lau, Eugene Lo, et al.
The Journal of Clinical Endocrinology and Metabolism|July 2, 2017
Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 DiabetesSue A Brown, Marc D Breton, Stacey M Anderson, et al.
JTO Clinical and Research Reports|April 9, 2024
Brief Report: Risk of Recurrent Interstitial Lung Disease From Osimertinib Versus Erlotinib Rechallenge After Symptomatic Osimertinib-Induced Interstitial Lung DiseaseMolly S C Li, Kirsty W C Lee, Kevin K S Mok, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 5, 2023
Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) StudyFarhana Islam, Leen Magarbeh, Samar S M Elsheikh, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 15, 2019
Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND reportNikita Nogovitsyn, Meghan Muller, Roberto Souza, et al.
JAMA Psychiatry|February 11, 2026
One-Year Actigraphy Study of Sleep and Rest-Activity Rhythms as Markers of Relapse in DepressionAndre C Tonon, Adile Nexha, Jasmyn E A Cunningham, et al.
Pageof 215